CD22 (Epratuzumab Biosimilar) Antikörper

Produktnummer ABIN7515694

Produktdetails anti-CD22 (Epratuzumab Biosimilar) Antikörper

Target: CD22 (Epratuzumab Biosimilar)

Reaktivität: Human

Wirt: Humanized

Klonalität: Monoklonal

Konjugat: Dieser CD22 (Epratuzumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS)

Verwendungszweck: Humanized recombinant monoclonal antibody raised against human CD22.

Spezifität: This antibody was prepared by the humanization of LL2, a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10 % of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity.

Kreuzreaktivität: Human

Immunogen: Original antibody is raised against by the humanization of LL2, a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10% of the molecule, with the remainder being human framework sequences, which greatly reduces

Klon: HL22

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Flow cytometry,The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu CD22 (Epratuzumab Biosimilar)

Target: CD22 (Epratuzumab Biosimilar)

Abstract: CD22 (Epratuzumab Biosimilar) Produkte

Synonyme: SIGLEC-2 antikoerper, SIGLEC2 antikoerper, CD22 molecule antikoerper, CD22 antikoerper

Substanzklasse: Biosimilar

Hintergrund: CD22 Molecule

Gen-ID: 933